title: [National study of adjuvant treatments of resected cholangiocarcinoma].
authors.forename: J-M
authors.initials: JM
authors.lastname: Phelip
authors.forename: E
authors.initials: E
authors.lastname: Boucher
authors.forename: X
authors.initials: X
authors.lastname: Roblin
authors.forename: M
authors.initials: M
authors.lastname: Baconnier
authors.forename: C
authors.initials: C
authors.lastname: Girault
authors.forename: L
authors.initials: L
authors.lastname: Bedenne
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001650:Bile Duct Neoplasms / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D018281:Cholangiocarcinoma / Q000601:surgery*; D002945:Cisplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005602:France; D006801:Humans; D015337:Multicenter Studies as Topic; D020360:Neoadjuvant Therapy; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine